Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease
Status:
Completed
Trial end date:
2019-02-06
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and tolerability of multiple doses of
NPT088 in patients with mild to moderate probable Alzheimer's Disease. The study will also
evaluate the pharmacokinetics, immunogenicity and exploratory pharmacodynamic characteristics
of multiple doses of NPT088.